SCHEMBL29204806

SCHEMBL29204806

COC(=O)c1ccc(N2CCN(c3cc(Cl)ccc3Cl)CC2)c(NC(=O)c2ccc(Cl)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 5/20 0.61
XPO1 O14980 2/20 0.57
ALDH1A1 P00352 2/20 0.53
HTT P42858 2/20 0.53
MCL1 Q07820 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
KDM4E B2RXH2 1/20 0.52
KMT2A Q03164 6/20 0.52
RBBP5 Q15291 1/20 0.52
ASH2L Q9UBL3 1/20 0.52
MEN1 O00255 3/20 0.50
MAPT P10636 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29204810 0.90 XPO1 (0.70) WDR5XPO1ALDH1A1HTTMCL1
SCHEMBL29204826 0.89 WDR5 (0.57) WDR5XPO1ALDH1A1RXFP1KDM4E
SCHEMBL29204830 0.87 XPO1 (0.69) XPO1ALDH1A1HTTMCL1KDM4E
SCHEMBL30883143 0.87 XPO1 (0.69) XPO1ALDH1A1HTTMCL1KDM4E
SCHEMBL29204813 0.85 WDR5 (0.57) WDR5XPO1ALDH1A1HTTRXFP1
SCHEMBL29204834 0.84 XPO1 (0.63) WDR5XPO1ALDH1A1RXFP1KDM4E
SCHEMBL29204824 0.83 XPO1 (0.61) WDR5XPO1KDM4EKMT2ARBBP5
SCHEMBL29204837 0.82 XPO1 (0.65) WDR5XPO1ALDH1A1HTTRXFP1
SCHEMBL29204841 0.81 XPO1 (0.66) WDR5XPO1ALDH1A1KDM4EKMT2A
SCHEMBL30883141 0.81 XPO1 (0.66) XPO1HTTMCL1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117964578-A Non-covalent CRM1 inhibitor and preparation method and application thereof 四川大学 2024-05-03 CN disclosed